Treatment Burden of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Randomized Study

CONTEXT: Somatrogon is a long-acting recombinant human growth hormone treatment developed as a once-weekly treatment for pediatric patients with growth hormone deficiency (GHD). OBJECTIVE: Evaluate patient and caregiver perceptions of the treatment burden associated with the once-weekly somatrogon i...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniatis, Aristides K, Carakushansky, Mauri, Galcheva, Sonya, Prakasam, Gnanagurudasan, Fox, Larry A, Dankovcikova, Adriana, Loftus, Jane, Palladino, Andrew A, de los Angeles Resa, Maria, Turich Taylor, Carrie, Dattani, Mehul T, Lebl, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463876/
https://www.ncbi.nlm.nih.gov/pubmed/36101713
http://dx.doi.org/10.1210/jendso/bvac117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463876/
https://www.ncbi.nlm.nih.gov/pubmed/36101713
http://dx.doi.org/10.1210/jendso/bvac117

Ejemplares similares